RichardADrachtmanMD

Pediatric Hematology & Oncology • New Brunswick, NJ

Physician

Join to view full profile

Dr. Drachtman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Drachtman's full profile

Already have an account?

Office
195 Little Albany Street
Rm 3038
New Brunswick, NJ 08901
Phone+1 732-235-5437

Fax+1 732-235-6462
Is this information wrong?

Education & Training

Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1984 - 1988
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1984

Certifications & Licensure

NJ State Medical License 1991 - 2025
NY State Medical License 1985 - 2004
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
Inside Jersey - Top Doctors for Children Castle Connolly, 2010-2014
America's Top Doctors Castle Connolly, 2009-2014
Inside Jersey Magazine Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
New York Magazine: Top Doctors Castle Connolly, 2002, 2005-2013
NJ.com Top Doctors Castle Connolly, 2009
New Jersey Life: Top Doctors Castle Connolly, 2005
New Jersey Monthly: Top Doctors Castle Connolly, 2001
Join now to see all

Clinical Trials

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Active, not recruiting
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Active, not recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Voxelotor Treatment Providing Transfusion Independence for Patient With Combined Sickle Cell Disease and Lipopolysaccharide-Responsive and Beige-Like Anchor (LRBA) Def...
Kelsey M Larkin, Archana Sharma, Liz Castro, Richard Drachtman> ;Cureus. 2023 Oct 1
Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study.
Clark Brown, Modupe Idowu, Richard Drachtman, Anne Beaubrun, Irene Agodoa, Andy Nguyen, Kelly Lipman, Olga Moshkovich, Ryan Murphy, M Alex Bellenger, Wally Smith> ;Biomed Research International. 2023 Jan 1
10 citations
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Paul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc, Maurizio Mascarin, Gérard Michel, Stacy Cooper, Auke Beishuizen, Kasey J Leger, Loredana Amoroso, Salvator...> ;Blood. 2023 Apr 27
4 citations
Supraclavicular lymphadenopathy after COVID-19 vaccination.
Kelsey Larkin, Archana Sharma, Richard Drachtman, Gratian Salaru> ;Pediatric Blood & Cancer. 2022 May 1
Survival of nonseminomatous germ cell tumors in pediatric patients and young adults - A stage group stratified analysis.
Arnav Srivastava, Hiren V Patel, Elizabeth Koehne, Gopal N Gupta, Richard Drachtman, Phillip M Pierorazio, Aditya Bagrodia, Sammy E Elsamra, Isaac Y Kim, Saum Ghodouss...> ;Urologic Oncology. 2022 Apr 1
Abnormal PET scan result after recent COVID vaccination.
Archana Sharma, Richard A. Drachtman> ;Pediatric Blood & Cancer. 2021 Jul 24
6 citations
A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.
S. Goldman, Matthew J. Barth, Bruce Shiramizu, Qiuhu Shi, Jessica Hochberg, Liana Klejmont, Lauren Harrison, Jackie Basso, Yaya Chu, Humayun Islam, Perry Gerard, Melis...> ;Leukemia. 2021 May 3
20 citations
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
James F. Casella, Bruce A. Barton, Julie Kanter, L. Vandy Black, Suvankar Majumdar, Adlette Inati, Yasser Wali, Richard A. Drachtman, Miguel R. Abboud, Yurdanur Kilinç...> ;JAMA. 2021 Apr 20
2 citations
Feasibility of Medical Student Mentors to Improve Transition in Sickle Cell Disease.
Adrienne Viola, Richard A. Drachtman, Amanda Kaveney, Ashwin Sridharan, Beth Savage, Cristine D. Delnevo, Elliot J. Coups, Jerlym S. Porter, Katie A. Devine> ;Journal of Pediatric Psychology. 2021 Jul 20
2 citations
Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma.
Karishma Khullar, Jesse J. Plascak, Richard A. Drachtman, Peter D. Cole, Rahul R. Parikh> ;Cancer Medicine. 2021 Jan 27
Atypical presentation of congenital thrombotic thrombocytopenic purpura with large and small vessel disease: A case report.
Debra Zharnest, Richard A. Drachtman, Susan Murphy, Margaret Masterson, Vikram Bhise, Scott Moerdler> ;Pediatric Blood & Cancer. 2020 Aug 1
6 citations
Pediatric hodgkin lymphoma: disparities in survival by race.
Karishma Khullar, Zorimar Rivera-Núñez, Sachin R. Jhawar, Richard A. Drachtman, Peter D. Cole, Bradford S. Hoppe, Rahul R. Parikh> ;Leukemia & Lymphoma. 2020 Feb 23
5 citations
Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluati...
Jocelyn Lewis, Kathleen M. McCarten, Lars Kurch, Jamie E. Flerlage, Sue C. Kaste, Regine Kluge, Dietrich Stoevesandt, Stephan D. Voss, Kara M. Kelly, C Mauz-Körholz, R...> ;Pediatric Blood & Cancer. 2020 Apr 1
1 citations
An Isolated Testicular Relapse of Burkitt's Lymphoma.
Young Suk Kwon, Faizanahmed I Munshi, Neeket R. Patel, Virian Serei, Nupam Patel, Richard A. Drachtman, Joseph G. Barone> ;Global Pediatric Health. 2019 Aug 30
16 citations
Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.
Sachin R. Jhawar, Zorimar Rivera-Núñez, Richard A. Drachtman, Peter D. Cole, Bradford S. Hoppe, Rahul R. Parikh> ;JAMA Oncology. 2019 May 1
2 citations
Primary Renal Ewing Sarcoma: A Case Report and Review of the Literature.
Bridget Lang Findlay, Brian Shinder, Evita Sadimin, Richard A. Drachtman, Rahul R. Parikh, Eric A. Singer> ;Journal of Renal Cancer. 2019 Jan 1
49 citations
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, mu...
Peter D. Cole, Kathleen M. McCarten, Qinglin Pei, Menachem Spira, Monika L. Metzger, Richard A. Drachtman, Terzah M. Horton, Rizvan Bush, Susan M. Blaney, Brenda J. We...> ;The Lancet. Oncology. 2018 Sep 1
16 citations
Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031.
Kathleen M. McCarten, Monika L. Metzger, Richard A. Drachtman, Qinglin Pei, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly> ;Pediatric Radiology. 2018 Jul 16
9 citations
Outcomes and patterns of care in a nationwide cohort of pediatric medulloblastoma: Factors affecting proton therapy utilization
Andrew Kopecky, Atif J. Khan, Wilbur Pan, Richard A. Drachtman, Rahul R. Parikh> ;Advances in Radiation Oncology. 2017 Jul 19
2 citations
Underutilization of proton therapy in the treatment of pediatric central nervous system tumors: an analysis of the National Cancer Database
Atif J. Khan, Benjamin H. Kann, Wilbur Pan, Richard A. Drachtman, Kenneth B. Roberts, Rahul R. Parikh> ;Acta Oncologica. 2017 Feb 13
8 citations
A Stroke Mimic: Methotrexate-induced Neurotoxicity in the Emergency Department.
Patrick J. Rogers, Wilbur Pan, Richard A. Drachtman, Christopher D. Haines> ;The Journal of Emergency Medicine. 2017 Apr 1
30 citations
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.
Jamie E. Flerlage, Kara M. Kelly, Auke Beishuizen, Steve Y. Cho, Pedro A. de Alarcon, Ute Dieckmann, Richard A. Drachtman, Bradford S. Hoppe, Scott C. Howard, Sue C. K...> ;Pediatric Blood & Cancer. 2017 Jul 1
11 citations
Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have dev...
Lisa Figueiredo, Peter D. Cole, Richard A. Drachtman> ;Expert Review of Hematology. 2016 Feb 19
2 citations
Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL).
Richard A. Drachtman, Margaret Masterson, Angela Shenkerman, Veena Vijayanathan, Peter D. Cole> ;Leukemia & Lymphoma. 2016 Feb 16
38 citations
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.
Lynda M. Vrooman, Ivan I. Kirov, Zo Ann E. Dreyer, Michael J. Kelly, Nobuko Hijiya, Patrick A. Brown, Richard A. Drachtman, Yoav H. Messinger, A. Kim Ritchey, Gregory ...> ;Pediatric Blood & Cancer. 2016 Feb 1
Join now to see all

Press Mentions

Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma PatientsSeptember 17th, 2019
Rutgers Cancer Institute of New Jersey Doctors Named Among ‘Tops’ in Oncology CareJuly 23rd, 2019
Rutgers Cancer Institute of New Jersey Pediatric Hematology/Oncology Section Chief Honored for Contributions to Cancer and Blood DisordersOctober 23rd, 2018
Join now to see all